NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380

Biology of Natural Killer Cells

Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896

NK CELL RECOGNITION

Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765

Immune surveillance of tumors

Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,518

Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming

Martin‐Fontecha, A., Thomsen, L. L., Brett, S. J., Gerard, C. J., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,351

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.

Bryceson, Y., March, M., Ljunggren, H., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 885

CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity

Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., & Caligiuri, M. A. (2003) · Blood · doi:10.1182/blood-2002-09-2876 · Cited by 879

Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030788 · Cited by 874

New aspects of natural-killer-cell surveillance and therapy of cancer

Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita∥, H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc928 · Cited by 750

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors

Koch, C., Kim, Y.-H., Zöller, T., Born, C., & Steinle, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01466 · Cited by 22

New avenues for melanoma immunotherapy: Natural Killer cells?

Cristiani, C. M., Garofalo, C., Passacatini, L. C., & Carbone, E. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12861 · Cited by 22

Tumor‐initiating properties of breast cancer and melanoma cells in vivo are not invariably reflected by spheroid formation in vitro, but can be increased by long‐term culturing as adherent monolayers

Kuch, V., Schreiber, C., Thiele, W., Umansky, V., & Sleeman, J. P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27785 · Cited by 21

Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer

Péraldi, M., Berrou, J., Venot, M., Chardiny, V., Dürrbach, A., Vieillard, V., Debré, P., Charron, D. J., Suberbielle, C., Chevret, S., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000792 · Cited by 22

Complement Receptor 3 Has Negative Impact on Tumor Surveillance through Suppression of Natural Killer Cell Function

Liu, C.-F., Min, X.-Y., Wang, N., Wang, J., Ma, N., Dong, X., Zhang, B., Wu, W., Li, Z., Zhou, W., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01602 · Cited by 22

The Role of Innate Immune Cells in Tumor Invasion and Metastasis

Huang, Y., Busuttil, R. A., & Boussioutas, A. (2021) · Cancers · doi:10.3390/cancers13235885 · Cited by 22

Human induced-T-to-natural killer cells have potent anti-tumour activities

Jiang, Z., Qin, L., Tang, Y., Liao, R. J., Shi, J., He, B., Li, S., Zheng, D., Cui, Y., Wu, Q., et al. (2022) · Biomarker Research · doi:10.1186/s40364-022-00358-4 · Cited by 20

IL12-mediated sensitizing of T-cell receptor-dependent and -independent tumor cell killing

Braun, M., Reß, M. L., Yoo, Y.-E., Scholz, C. J., Eyrich, M. K., Schlegel, P. G., & Wölfl, M. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1188245 · Cited by 20

Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAF V600E Melanoma Lines with Vemurafenib

Frazao, A., Colombo, M., Fourmentraux-Neves, E., Messaoudene, M., Rusakiewicz, S., Zitvogel, L., Vivier, É., Vely, F., Faure, F., Dréno, B., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0380 · Cited by 20

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression

Glasner, A., Isaacson, B., Viukov, S. V., Neuman, T., Friedman, N., Mandelboim, M., Sexl, V., Hanna, J. H., & Mandelboim, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-12998-w · Cited by 20

Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme

Koliaraki, V., Henriques, A. R., Prados, A., & Kollias, G. A. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190457 · Cited by 20

Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé

Glasner, A., Šimić, H., Miklić, K., Roth, Z., Berhani, O., Khalaila, I., Jonjić, S., & Mandelboim, O. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501234 · Cited by 19

Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1

Deuss, F. A., Watson, G. M., Goodall, K. J., Leece, I., Chatterjee, S., Fu, Z., Thaysen‐Andersen, M., Andrews, D. M., Rossjohn, J., & Berry, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009261 · Cited by 19

Human Herpesviridae Methods of Natural Killer Cell Evasion

Odom, C. I., Gaston, D. C., Markert, J. M., & Cassady, K. A. (2012) · Advances in Virology · doi:10.1155/2012/359869 · Cited by 19

Anchorage-independent growth of Ewing sarcoma cells under serum-free conditions is not associated with stem-cell like phenotype and function

Leuchte, K., Altvater, B., Hoffschlag, S., Potratz, J. C., Meltzer, J., Clemens, D., Luecke, A., Hardes, J., Dirksen, U., Juergens, H., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3269 · Cited by 19

The Uncovered Role of Immune Cells and NK Cells in the Regulation of Bone Metastasis

Roato, I., & Vitale, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00145 · Cited by 18

Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/−DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia

Jang, J. E., Hwang, D. Y., Chung, H., Kim, S., Eom, J.-I., Jeung, H.-K., Song, J., Kim, J. S., Cheong, J., & Min, Y. H. (2019) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2019.06.008 · Cited by 18

Immunosurveillance of cancer cell stress

Lorenzo‐Herrero, S., Sordo‐Bahamonde, C., Gonzalez, S. R., & López‐Soto, A. (2019) · Cell Stress · doi:10.15698/cst2019.09.198 · Cited by 18

CD226 interaction with CD155 impacts on retention and negative selection of CD8 positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's Patches

Danisch, S., Qiu, Q., Seth, S., Ravens, I., Dorsch, M. M., Shibuya, A., Shibuya, K., Förster, R., & Bernhardt, G. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.02.010 · Cited by 18

Broad Impairment of Natural Killer Cells From Operationally Tolerant Kidney Transplanted Patients

Dugast, E., David, G., Oger, R., Danger, R., Judor, J., Gagne, K., Chesneau, M., Degauque, N., Soulillou, J., Paul, P., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01721 · Cited by 18

Innate Lymphoid Cells in Skin Homeostasis and Malignancy

Wagner, M., & Koyasu, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758522 · Cited by 19

The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations

Jinna, N., Rida, P. C. G., Su, T., Gong, Z., Yao, S., LaBarge, M. A., Natarajan, R. D., Jovanović‐Talisman, T., Ambrosone, C. B., & Seewaldt, V. L. (2022) · Cells · doi:10.3390/cells11233818 · Cited by 21

Natural killer cells- from innate cells to the discovery of adaptability

Basílio-Queirós, D., & Weissinger, E. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1172437 · Cited by 17

The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes

Gur, C., Enk, J., Weitman, E., Bachar-Wikström, E., Suissa, Y., Cohen, G., Schyr, R. B., Sabanay, H., Horwitz, E. P., Gläser, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074033 · Cited by 17

TNF-α–Dependent Hematopoiesis following Bcl11b Deletion in T Cells Restricts Metastatic Melanoma

Uddin, M. N., Zhang, Y., Harton, J. A., MacNamara, K. C., & Avram, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301976 · Cited by 17

Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy

Rethacker, L., Roelens, M., Bejar, C., Maubec, E., Moins‐Teisserenc, H., & Caignard, A. (2021) · Cancers · doi:10.3390/cancers13061446 · Cited by 17

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function

Manzini, C., Venè, R., Cossu, I., Gualco, M., Zupo, S., Dono, M., Spagnolo, F., Queirolo, P., Moretta, L., Mingari, M. C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11504 · Cited by 16

Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia

Szereday, L., Nagy, D. U., Csiszár, B., Kevey, D. K., Feik, T., & Meggyes, M. (2021) · Biomedicines · doi:10.3390/biomedicines9111608 · Cited by 16

Microenvironmental modulation of the developing tumour: an immune‐stromal dialogue

Jones, J. O., Moody, W. M., & Shields, J. D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12773 · Cited by 16

Targeting novel inhibitory receptors in cancer immunotherapy

Ding, Q., Chauvin, J.-M., & Zarour, H. M. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101436 · Cited by 16

CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy

Mu, Y., & Guan, X. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230324152532 · Cited by 15

The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies

Rahimi, A., Malakoutikhah, Z., Rahimmanesh, I., Ferns, G. A., Nedaeinia, R., Ishaghi, S. M. M., Dana, N., & Javanmard, S. H. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03134-y · Cited by 15

T cells in tumor microenvironment

Kiraz, Y., Baran, Y., & Nalbant, A. (2015) · Tumor Biology · doi:10.1007/s13277-015-4241-1 · Cited by 19

The Role of Activating and Inhibitory NK Cell Receptors in Antitumor Immune Response

Konjević, G. M., Vuletić, A. M., Martinović, K. M., & Džodić, R. R. (2017) · InTech eBooks · doi:10.5772/intechopen.69729 · Cited by 15

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies

Liu, G., Qiu, Y., Zhang, P., Chen, Z., Chen, S., Huang, W., Wang, B., Yu, X., & Guo, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091762 · Cited by 14

Antihypertensives and melanoma: An updated review

Williams, N. M., Vincent, L. T., Rodriguez, G. A., & Nouri, K. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12918 · Cited by 14

Innate lymphoid cells in early tumor development

Warner, K., Ghaedi, M., Chung, D. C., Jacquelot, N., & Ohashi, P. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.948358 · Cited by 13

Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate

Millard, A., Spirig, R., Mueller, N. J., Seebach, J. D., & Rieben, R. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.05.284 · Cited by 13

Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk

Chinnery, F., KING, C. A., Elliott, T. J., Bateman, A. R., & James, E. (2012) · OncoImmunology · doi:10.4161/onci.20636 · Cited by 12

Natural Cytotoxicity of NC‐2+ Cells Against the Growth and Metastasis of WEHI‐164 Fibrosarcoma

Shirzad, H., Burton, R. C., Smart, Y. C., Rafieian‐Kopaei, M., & Shirzad, M. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02481.x · Cited by 12

Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity

Glasner, A., Roth, Z., Varvak, A., Miletić, A., Isaacson, B., Bar‐On, Y., Jonjić, S., Khalaila, I., & Mandelboim, O. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.36 · Cited by 11

SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses

Molfetta, R., Petillo, S., Cippitelli, M., & Paolini, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1213114 · Cited by 12

The use of microRNA by human viruses: lessons from NK cells and HCMV infection

Goldberger, T., & Mandelboim, O. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0447-3 · Cited by 11

Mechanical Stress Downregulates MHC Class I Expression on Human Cancer Cell Membrane

Rocca, R. L., Tallerico, R., Hassan, A. T., Das, G., Lakshmikanth, T., Matteucci, M., Liberale, C., Mesuraca, M., Scumaci, D., Gentile, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111758 · Cited by 10

CD226 gene polymorphism (rs763361 C>T) is associated with susceptibility to type 1 diabetes mellitus among Egyptian children

El-Ella, S. A., Khattab, E. S. A. E. H., El-Mekkawy, M. S., & Elshamy, A. M. (2018) · Archives de Pédiatrie · doi:10.1016/j.arcped.2018.06.009 · Cited by 10

Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6

Woelk, J., Hornsteiner, F., Wallner, S., Stoitzner, P., Baier, G., & Hermann‐Kleiter, N. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07407-4 · Cited by 9

NK cell expansion requires HuR and mediates control of solid tumors and long-term virus infection

Piersma, S. J., Bangru, S., Yoon, J., Liu, T. W., Yang, L., Hsieh, C., Plougastel-Douglas, B., Kalsotra, A., & Yokoyama, W. M. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20231154 · Cited by 9

The tricks for fighting against cancer using CAR NK cells: A review

Vahidian, F., Khosroshahi, L. M., Akbarzadeh, M., Jahanban‐Esfahlan, A., Baghbanzadeh, A., Ali‐Hassanzadeh, M., & Safarzadeh, E. (2022) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2022.101817 · Cited by 9

Interleukin signaling in the regulation of natural killer cells biology in breast cancer

Xu, J., Gao, H., Azhar, M., Xu, H.-F., Chen, S., Li, M., Ni, X., Yan, T., Zhou, H., Long, Q., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1449441 · Cited by 8

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

Tallerico, R., Cristiani, C. M., Capone, M., Madonna, G., Mallardo, D., Simeone, E., Dominijanni, A., Grimaldi, A. M., Colucci, F., Ascierto, P. A., et al. (2015) · Journal of Translational Medicine · doi:10.1186/1479-5876-13-s1-o8 · Cited by 8

Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling

Wu, L., Park, S.-H., Jakobsson, H., Shackleton, M. J., & Möller, A. (2024) · Cancers · doi:10.3390/cancers16111950 · Cited by 9

Natural killer cells in skin: a unique opportunity to better characterize the many facets of an overlooked secondary lymphoid organ

Johnson, K. M., & Lee, D. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646719 · Cited by 7

Enhancing natural killer cell anti-tumour activity through macrophage manipulation

Palmer, N., Khakoo, S. I., Sánchez-Elsner, T., & Vallejo, A. F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656925 · Cited by 11

Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noé)

Glasner, A., Isaacson, B., & Mandelboim, O. (2017) · Scientific Reports · doi:10.1038/srep40944 · Cited by 7

The Role of NK Cells in Cancer

Jurišić, V., Vuletić, A. M., Martinović, K. M., & Konjević, G. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_9 · Cited by 7

MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

López-Borrego, S., Campos‐Silva, C., Sandúa, A., Camino, T., Téllez-Pérez, L., Alegre, E., Beneítez‐Martínez, A., Jara‐Acevedo, R., Paschen, A., Pardo, M., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1055288 · Cited by 8

Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma.

Collignon, A., Silvy, F., Robert, S., Trad, M., Germain, S., Nigri, J., André, F., Rigot, V., Tomasini, R., Bonnotte, B., et al. (2018) · PubMed Central · doi:10.1080/2162402x.2018.1504727 · Cited by 7

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells

van Vliet, A. A., Peters, E., Vodegel, D., Steenmans, D., Raimo, M., Gibbs, S., de Gruijl, T. D., Duru, A. D., Spanholtz, J., & Georgoudaki, A. (2023) · iScience · doi:10.1016/j.isci.2023.107078 · Cited by 7

Natural killer cels in immunotherapy for cancer

Боробова, Е. А., & Жеравин, А. А. (2019) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2018-17-6-97-104 · Cited by 7

Impact of serum soluble CD155 level at diagnosis on interim response to CHOP with or without rituximab in diffuse large B cell lymphoma

Azzazi, M. O., Hegab, H. M. A.-A., El-Ghammaz, A. M. S., Saber, H., & Afifi, Y. A. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00741-9 · Cited by 7

A Simple Method to Measure NK Cell Cytotoxicity In Vivo

Saudemont, A., Burke, S., & Colucci, F. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-362-6_22 · Cited by 7

Deficiency of platelet adhesion molecule CD226 causes megakaryocyte development and platelet hyperactivity

Zhang, J., Ding, Y., Jiang, D., Xie, J., Liu, Y., Ma, J., Mu, Y., Zhang, X., Yu, C., Zhang, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902142r · Cited by 7

Senescent Polarization of Macrophages and Inflammatory Biomarkers in Cardiovascular Disease

Ihan, A. (2025) · Cells · doi:10.3390/cells14171374 · Cited by 6

Splenectomy has opposite effects on the growth of primary compared with metastatic tumors in a murine colon cancer model

Kaneko, Y., Miyato, H., Tojo, M., Futoh, Y., Takahashi, K., Kimura, Y., Saito, A., Ohzawa, H., Yamaguchi, H., Sata, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-54768-5 · Cited by 6

NK/DC crosstalk in immunosurveillance: A broken relationship caused by WASP‐deficiency

Romagnani, C., & Babić, M. (2014) · European Journal of Immunology · doi:10.1002/eji.201444514 · Cited by 6

Taming killer cells may halt diabetes progression

Colucci, F., & Cilio, C. (2010) · Nature Immunology · doi:10.1038/ni0210-111 · Cited by 6

Overview of Immune System

Rotte, A., & Bhandaru, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-48066-4_5

Chronic Ly49H Receptor Engagement in vivo Decreases NK Cell Response to Stimulation Through ITAM-Dependent and Independent Pathways Both in vitro and in vivo

Key, P. N., Germino, J., Yang, L., Piersma, S. J., & Tripathy, S. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01692 · Cited by 6

Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment

Carreira, B., Acúrcio, R. C., Matos, A. I., Peres, C., Pozzi, S., Vaskovich‐Koubi, D., Kleiner, R., Bento, M., Satchi‐Fainaro, R., & Florindo, H. F. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000147 · Cited by 6

Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review

Mai, C., Fukui, A., Saeki, S., Takeyama, R., Yamaya, A., & Shibahara, H. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12610 · Cited by 6

Harnessing host innate immunity may combat acquired resistance to BRAFi

Tan, T., Pangigadde, P., Sabbatino, F., Favoino, E., Orgiano, L., Ferrone, S., Carbone, E., & Colucci, F. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-s1-o10 · Cited by 5

Effector and cytolytic function of natural killer cells in anticancer immunity

Karmakar, S., Mishra, A., Pal, P., & Lal, G. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad126 · Cited by 5

Transmission of “split anergy” from tumor infiltrating to peripheral NK cells in a manner similar to “infectious tolerance”

Belyaev, N. N., & Abramova, V. A. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.019 · Cited by 5

Adaptive features of natural killer cells, lymphocytes of innate immunity

Kovalenko, E. I., & Streltsova, M. A. (2016) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162016060066 · Cited by 5

Suppression of Th1 and Th17 Proinflammatory Cytokines and Upregulation of FOXP3 Expression by a Humanized Anti-DNAM-1 Monoclonal Antibody

Yamashita-Kanemaru, Y., Oh‐oka, K., Abe, F., Shibuya, K., & Shibuya, A. (2021) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2020.0042 · Cited by 5

Receptors of immune cells mediates recognition for tumors

Anang, V., Singh, A., Kottarath, S. K., & Verma, C. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.09.009 · Cited by 5

An engineered NKp46 antibody for construction of multi-specific NK cell engagers

Lee, R. B., Maddineni, S., Landry, M. R., Diaz, C., Tashfeen, A., Yamada‐Hunter, S. A., Mackall, C. L., Beinat, C., Sunwoo, J. B., & Cochran, J. R. (2024) · Protein Engineering Design and Selection · doi:10.1093/protein/gzae013 · Cited by 5

Nonclassical NK cell education

Held, W. (2012) · Nature Immunology · doi:10.1038/ni.2470 · Cited by 5

Regulation of Immune Cell Functions through Nectin and Nectin-Like Receptors

Martinet, L., & Smyth, M. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.02010-5 · Cited by 6

NK cells promote cardiac cell death and regulate myelopoiesis in myocardial infarction

Cohen, R., Duval, V., Al-Rifai, R., Maryam, S., Santos‐Zas, I., Braik, R., Diedisheim, M., Jouve, C., Nicoletti, S., Thietart, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71334-x · Cited by 5

Natural killer cells control metastasis via structural editing of primary tumors in mice

Isaacson, B., & Mandelboim, O. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02405-w · Cited by 4

Augmentation of Cytolytic Activity in Murine Natural Killer Cells and Inhibition of Tumor Growth by the Ethanol Fraction of Oyster Extract

Sakaguchi, K., Zhong, M., Kawai, S., Shimizu, Y., & Gohda, E. (2016) · Integrative Cancer Therapies · doi:10.1177/1534735416681640 · Cited by 4

Die Nutzung natürlicher Killerzellen für die Therapie des Melanoms

Hölsken, O., Miller, M., & Cerwenka, A. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12557_suppl · Cited by 3

HIV-1 manipulates CD96 on CD4 + T cells to subvert antiviral immunity

Dehn, S., Burkhard, R., Leyens, J., Kaiser, T., Brandimarte, S., Heiligensetzer, D., Koppensteiner, H., Bajoghli, B., Hailfinger, S., Schilbach, K., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx7485 · Cited by 3

CAR-T cell immunotherapy of malignant melanoma

Kharasakhal, O., & Maher, J. F. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2026.2621811 · Cited by 3

From mice to men: An assessment of preclinical model systems for the study of vitiligo

Wu, W., Wang, X., He, K., Li, C., & Li, S. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110171 · Cited by 3

CD96: immunoregulation and its role and prospect in immunotherapy of primary hepatocellular carcinoma

Chai, J., Li, L., Wu, Q., & Zhang, S. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002916 · Cited by 3

Selection of tumor‑resistant variants following sustained natural killer cell‑mediated immune stress

Carré, T., Thiery, J., Janji, B., Terry, S., Gros, G., Meurice, G., Kiéda, C., Olive, D., & Chouaı̈b, S. (2020) · Oncology Reports · doi:10.3892/or.2020.7872 · Cited by 3

Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer

Onuma, T., Asare-Werehene, M., Fujita, Y., Yoshida, Y., & Tsang, B. K. (2024) · Cells · doi:10.3390/cells13110905 · Cited by 3

Integration of the DNA Damage Response with Innate Immune Pathways

Gordon, M., & Gasser, S. (2011) · InTech eBooks · doi:10.5772/24735 · Cited by 3

Current Perspectives on Immunomodulation of NK Cells in Melanoma

Lakshmikanth, T., & Maria, H. (2011) · InTech eBooks · doi:10.5772/23903 · Cited by 3

Virus Immune Evasion: New Mechanism and Implications in Disease Outcome

Draenert, R., Frater, J., & Prado, J. G. (2012) · Advances in Virology · doi:10.1155/2012/490549 · Cited by 2

The Natural Killer Cell - 'Missing-Self' Recognition Strategy

Lakshmikanth, T., Kärre, K., & Sreerama, K. (2011) · Cited by 3

Correction: Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 Diabetes

Berrou, J., Fougeray, S., Venot, M., Chardiny, V., Gautier, J., Dulphy, N., Toubert, A., & Péraldi, M. (2014) · PLoS ONE · doi:10.1371/annotation/c6fd65ca-7ab4-4407-ac23-2b9144073dce · Cited by 3

Melanoma of unknown primary: a comprehensive review of immune-mediated pathogenesis and therapies

Xu, W., Gui, J., Guo, P., Zhang, Y., & Wu, D. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf410 · Cited by 2

Targeting natural killer cells in cancer immunotherapy

Matosevic, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00003-8 · Cited by 2

Genomics, Proteomics, and Metabolomics of Cancer Stem Cells (CSCs)

Khatami, F., Tavangar, S. M., & Pour, N. K. (2019) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-27727-7_9 · Cited by 2

Functional Role of Uterine Natural Killer Cells

Fukui, A., Funamizu, A., Fuchinoue, K., Kamoi, M., Taima, A., Fukuhara, R., & Mizunuma, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55972-6_5 · Cited by 1

New therapeutic modalities in breast cancer by targeting NK cell inhibitory and activating receptors

Moyal, L., Navasardyan, I., & Bonavida, B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00017-5 · Cited by 1

NK Cell Recognition and Killing of Melanoma Cells Is Controlled by Multiple Activating Receptor-Ligand Interactions

Morgado, S., Sánchez-Correa, B., Casado, J. G., Durán, E., Gayoso, I., Labella, F., Solana, R., & Tarazona, R. (2011) · Journal of Innate Immunity · doi:10.1159/000328505 · Cited by 59

Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands

Solana, R., Casado, J. G., Delgado, E., DelaRosa, O., Marín, J., Durán, E., Pawelec, G., & Tarazona, R. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0141-y · Cited by 40

DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases

Chan, C. J., Andrews, D. M., McLaughlin, N. M., Yagita∥, H., Gilfillan, S., Colonna, M., & Smyth, M. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0903225 · Cited by 191

Natural killer cells as potential tools in melanoma metastatic spread control.

Nasca, R., & Carbone, E. (1999) · PubMed · Cited by 9

Estudio de las interacciones receptor-ligando entre células natural killer y líneas celulares de melanoma

García, S. M. (2011) · Dialnet (Universidad de la Rioja)